Search tips
Search criteria 


Logo of plospathPLoS PathogensSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)View this Article
PLoS Pathog. 2010 October; 6(10): e1001133.
Published online 2010 October 7. doi:  10.1371/journal.ppat.1001133
PMCID: PMC2951371

Staphylococcus epidermidis Strategies to Avoid Killing by Human Neutrophils

Michael S. Gilmore, Editor


Staphylococcus epidermidis is a leading nosocomial pathogen. In contrast to its more aggressive relative S. aureus, it causes chronic rather than acute infections. In highly virulent S. aureus, phenol-soluble modulins (PSMs) contribute significantly to immune evasion and aggressive virulence by their strong ability to lyse human neutrophils. Members of the PSM family are also produced by S. epidermidis, but their role in immune evasion is not known. Notably, strong cytolytic capacity of S. epidermidis PSMs would be at odds with the notion that S. epidermidis is a less aggressive pathogen than S. aureus, prompting us to examine the biological activities of S. epidermidis PSMs. Surprisingly, we found that S. epidermidis has the capacity to produce PSMδ, a potent leukocyte toxin, representing the first potent cytolysin to be identified in that pathogen. However, production of strongly cytolytic PSMs was low in S. epidermidis, explaining its low cytolytic potency. Interestingly, the different approaches of S. epidermidis and S. aureus to causing human disease are thus reflected by the adaptation of biological activities within one family of virulence determinants, the PSMs. Nevertheless, S. epidermidis has the capacity to evade neutrophil killing, a phenomenon we found is partly mediated by resistance mechanisms to antimicrobial peptides (AMPs), including the protease SepA, which degrades AMPs, and the AMP sensor/resistance regulator, Aps (GraRS). These findings establish a significant function of SepA and Aps in S. epidermidis immune evasion and explain in part why S. epidermidis may evade elimination by innate host defense despite the lack of cytolytic toxin expression. Our study shows that the strategy of S. epidermidis to evade elimination by human neutrophils is characterized by a passive defense approach and provides molecular evidence to support the notion that S. epidermidis is a less aggressive pathogen than S. aureus.

Author Summary

Staphylococcus epidermidis frequently causes chronic infections, indicating pronounced capacity to evade host defenses. However, S. epidermidis is in general much less aggressive than its close relative, S. aureus. Here we identify molecular underpinnings of that discrepancy by showing that S. epidermidis immune evasion mechanisms are limited to those involving molecules that protect against or eliminate antimicrobial agents secreted by white blood cells, while immune evasion mechanisms of virulent S. aureus include the production of destructive toxins. This is especially noteworthy, because we demonstrate here for the first time that S. epidermidis has the capacity to produce a toxin with great potential to destroy white blood cells, but keeps its production at a very limited level. Thus, our study shows that two closely related human pathogens have adapted specific molecular mechanisms to evade host defenses, reflecting the unique approach used by each to cause human disease.


Staphylococcus epidermidis colonizes the epithelial surfaces of every human being. Furthermore, it is one of the most frequent causes of nosocomial infections. In addition to the abundant prevalence of S. epidermidis on the human skin, this high incidence is mainly due to the exceptional capacity of S. epidermidis to stick to the surfaces of indwelling medical devices during device insertion and form multilayered agglomerations called biofilms [1], [2].

During infection, S. epidermidis is exposed to human innate host defenses, most notably professional phagocytes, among which neutrophils or polymorphonuclear leukocytes (PMNs) play a preeminent role [3]. While the biofilm mode of growth is believed to be broadly protective against host defenses [1], [4], we lack information on specific molecules of S. epidermidis that provide resistance to host defense mechanisms. The only S. epidermidis molecules known to facilitate evasion of killing by neutrophils are the extracellular polymers poly-N-acetylglucosamine (PNAG, or PIA, polysaccharide intercellular adhesin) and poly-γ-glutamic acid (PGA), which inhibit uptake by neutrophils (phagocytosis) [5], [6]. This is in contrast to S. aureus, a more pathogenic relative of S. epidermidis, which produces a series of proteins and enzymes dedicated to evade innate and adaptive host defense [7], [8].

Immune evasion of S. aureus is due in part to cytolytic toxins, such as α-toxin, γ-toxin, or Panton-Valentine leukocidin, which are proinflammatory and have potential to lyse neutrophils and other leukocytes [9]. In addition, we recently identified a new class of S. aureus cytolytic toxins, the phenol-soluble modulins (PSMs). Several PSM peptides have high capacity to attract, stimulate and lyse human neutrophils, and are significant contributors to pathogenesis of S. aureus bacteremia and skin infection [10]. PSMα3, in particular, is the most cytolytic S. aureus PSM and encoded together with three other PSMs in the psmα operon of S. aureus. High expression of peptides encoded in the psmα operon is mainly responsible for the pronounced potential of hyper-virulent community-associated methicillin-resistant S. aureus (CA-MRSA) strains to lyse human neutrophils [10], underpinning the importance of PSMs for neutrophil lysis. In contrast to S. aureus, toxins that lyse human leukocytes or other cell types have not been described in S. epidermidis.

PSMs are characterized by common physico-chemical properties rather than similarity at the amino acid sequence level (Fig. 1). Identification of PSMs thus requires isolation and characterization by means such as mass spectrometry and Edman degradation. Using these methods, six members of the PSM family have been identified in S. epidermidis (Fig. 1) [11], [12], [13], [14], but their biological significance is largely undefined. This is in part due to the fact that in earlier studies, a partially purified extract from S. epidermidis containing PSMs was used to measure PSM activities [12], [15], [16], [17]. Therefore, it is possible that proinflammatory activities previously attributed to S. epidermidis PSMs were caused by contaminants such as lipopeptides, particularly as similar impurities have frequently led to the misinterpretation of stimulatory effects on innate immune system mechanisms in the past [18]. This emphasizes the need to analyze pure peptides, but pure S. epidermidis PSMs and especially cytolytic potencies of S. epidermidis PSMs have never been investigated.

Figure 1
S. epidermidis and S. aureus PSMs.

After phagocytosis, neutrophils kill bacteria with reactive oxygen species and non-oxygen-dependent processes [19]. Among the latter, antimicrobial peptides (AMPs) such as defensins and cathelicidins are believed to play a crucial role [20]. We have previously found that the secreted S. epidermidis protease SepA has considerable capacity to eliminate AMPs by proteolysis [21]. Furthermore, we identified the first Gram-positive AMP sensing system in S. epidermidis, apsRSX [22]. This system, which has also been named graRSX in S. aureus [23], [24], regulates a series of AMP resistance mechanisms, including Dlt-dependent D-alanylation of teichoic acids [25], MprF-dependent lysinylation of phospholipids [26], and an AMP exporter called VraFG [24]. However, it is not known whether Aps or SepA confer resistance to killing by neutrophils.

In the present study, we examined the role of S. epidermidis PSMs in immune evasion, in particular by determining whether S. epidermidis PSMs are cytolytic toward human neutrophils. Furthermore, we analyzed whether the sepA and apsRSX loci facilitate survival during phagocytic interaction with neutrophils. Our study provides a better understanding of how S. epidermidis evades killing by human leukocytes in the susceptible host. Notably, we identified the first potent S. epidermidis cytolysin, PSMδ, a member of the α-type PSM family. However, despite the capacity to produce a potent cytolysin, S. epidermidis culture supernatants had little or no capacity to lyse neutrophils. In contrast, we show that the SepA protease and the Aps AMP sensor significantly promote resistance of S. epidermidis to killing by neutrophils. These findings provide molecular evidence to support the notion that S. epidermidis, in strong contrast to virulent S. aureus, has a defensive rather than aggressive approach to infection and immune evasion.


Cytolytic activity of S. epidermidis culture filtrates

To evaluate the relative potency of S. epidermidis to kill human neutrophils, we compared culture filtrates of different S. epidermidis strains with those of S. aureus LAC, a CA-MRSA strain with demonstrated high capacity to lyse neutrophils [10], [27]. We investigated four S. epidermidis strains that have been most frequently used in S. epidermidis pathogenesis studies: 1457, O47, ATCC12228, and RP62A. ATCC12228 and RP62A represent the two S. epidermidis strains for which genome sequence data are available [14], [28]. Furthermore, we included an agr mutant of strain 1457, as the agr regulatory system is known to strictly regulate PSM production [10], [29], [30].

Culture filtrates of all four S. epidermidis strains showed significantly reduced lysis of human neutrophils compared to S. aureus LAC (Fig. 2), indicating that as a species S. epidermidis has low capacity to lyse neutrophils. Some low-level cytolysis was detected in culture filtrates from strain 1457, but not strains RP62A and ATCC12228. Furthermore, cytolytic capacity of culture filtrates was completely abolished in an agr deletion mutant of strain 1457 and in the natural agr mutant strain O47 (Fig. 2), in accordance with a potential function of the agr-regulated PSMs of S. epidermidis in neutrophil lysis.

Figure 2
Neutrophil lysis by S. epidermidis culture filtrates.

Analysis of PSM secondary structure

In vitro studies using S. aureus and S. epidermidis γ-toxins and S. epidermidis PSMδ indicated that PSMs lead to perturbation of synthetic membrane vesicles and likely work by pore formation in the absence of a specific receptor [31], [32], [33]. Presumably, the capacity of PSMs to lyse cells is thus dependent on their physico-chemical features, namely the ability to form amphipathic α-helices, a characteristic property of pore-forming peptides.

To evaluate whether S. epidermidis PSMs form amphipathic α-helices, we determined secondary structures of PSM peptides using circular dichroism (Fig. 3A, B). These experiments demonstrated that all S. epidermidis PSMs are predominantly α-helical. When PSM sequences were arranged in α-helical wheels, all predicted α-helices showed a distinct hydrophilic opposed to a hydrophobic side, which is characteristic for amphipathic α-helices (shown as an example for PSMβ1 in Fig. 3C). These findings indicate that S. epidermidis PSMs have the basic structural requirements for membrane perturbation and pore formation.

Figure 3
Secondary structure of S. epidermidis PSM peptides.

Capacity of S. epidermidis PSMs to lyse neutrophils

To analyze whether S. epidermidis PSMs lyse neutrophils, we incubated human neutrophils with pure, synthetic S. epidermidis PSMs. Remarkably, one S. epidermidis PSM, PSMδ, caused high levels of neutrophil lysis, to an extent comparable to that of the potent S. aureus PSMα3 (Fig. 4A). In contrast, S. epidermidis δ-toxin, PSMα, and PSMε showed only very limited cytolytic capacity. The β-type PSMs were non-cytolytic toward neutrophils, in keeping with findings achieved for the β-type PSMs of S. aureus [10]. These differences indicate that while the formation of amphipathic α-helices is a likely prerequisite for membrane perturbation, further yet unknown structural features determine the degree of cytolytic activity in PSMs. This notion is also supported by our observation that the degree of α-helicity (Fig. 3A) did not correlate with the cytolytic potential of PSMs (Fig. 4A). Of note, PSMδ to our knowledge represents the first potent cytolysin of S. epidermidis to be identified. Remarkably, PSMδ is less closely related to S. aureus PSMα3 by amino acid sequence comparison than are PSMα1, PSMα2, and S. epidermidis PSMε (Fig. 1), underlining the notion that cytolytic properties of PSMs are determined by secondary rather than primary structure.

Figure 4
Neutrophil lysis by S. epidermidis PSM peptides and culture filtrates of PSMδ-expression strains.

The strong potency of PSMδ to lyse human neutrophils was confirmed by expression of PSMδ in an agr-negative S. epidermidis strain that lacks production of PSMs (Fig. 4B). Induction of PSMδ production resulted in a significant increase in the capacity of culture filtrates from the agr-negative strain to lyse human neutrophils (p = 0.0015, agr pTXpsmδ versus agr pTX16 control). As we have observed previously [10], [34], plasmid-based expression of PSM peptides often does not result in concentrations of PSMs as high as those found in wild-type culture filtrates, which also was the case for PSMδ. However, the degree of neutrophil lysis exerted by culture filtrates of the PSMδ expression strain (20.1% of that by the wild-type) corresponded very well to PSMδ expression (18.6% of that in the wild-type) (Fig. 4B), highlighting the major contribution PSMδ has to the overall cytolytic capacity of S. epidermidis.

Hemolytic activity of S. epidermidis PSMs

We showed previously that S. aureus PSMs also lyse cells other than neutrophils, such as monocytes or erythrocytes [10]. To analyze whether lysis of erythrocytes by synthetic PSMs and staphylococcal culture filtrates follows the same pattern as observed using human neutrophils, we tested hemolysis. Results were in very good accordance with those achieved with human neutrophils, inasmuch as only PSMδ showed strong hemolytic activity at a level comparable to that exerted by S. aureus PSMα3 (Fig. 5A). Similarly, culture filtrates of S. epidermidis strains were much less hemolytic than those of S. aureus LAC, with that of S. epidermidis 1457 causing slightly higher hemolysis than culture filtrates from the other S. epidermidis strains (Fig. 5B), in keeping with the neutrophil lysis findings.

Figure 5
Hemolysis by S. epidermidis culture filtrates and PSM peptides.

Production characteristics of PSMs in S. epidermidis

The finding that S. epidermidis PSMδ has considerable cytolytic activity at first appeared to contradict the low cytolytic activity of S. epidermidis culture filtrates. Indeed, it was reminiscent of the situation in S. aureus, in which the cytolytic potential is also mostly determined by one strongly cytolytic PSM peptide, PSMα3 [10]. However, potential differences in PSM production are not considered in this comparison. Therefore, we next measured PSM production patterns in S. epidermidis strains compared to those in S. aureus. We found considerable differences in the relative PSM production patterns between S. aureus and S. epidermidis, while patterns among the different S. epidermidis strains were similar (Fig. 6). In addition to the S. epidermidis strains that are shown, we analyzed a large S. epidermidis strain collection. Results were similar in all strains, except for strains that completely lacked PSM production (data not shown). These PSM-negative strains are likely functionally agr-negative, owing to frequently occurring mutations in the agr system [35], which includes the agr-negative strain O47 [36].

Figure 6
PSM concentrations in S. epidermidis culture filtrates.

The most noticeable difference between S. epidermidis and S. aureus was strongly reduced production of α-type PSMs, except δ-toxin, in S. epidermidis. In contrast, the non-cytolytic β-type PSMs represented almost half of the total PSM peptide produced in S. epidermidis, whereas concentrations of β-type PSMs were extremely low in S. aureus. Furthermore, the difference between the production levels of the most cytolytic PSMs in the two species, PSMα3 and PSMδ (~5[ratio]1), correlated with the degree of overall neutrophil lysis (~5[ratio]1, S. aureus LAC to S. epidermidis 1457), underlining that these most potent PSMs predominantly determine cytolytic capacity. Moreover, the notion that any cytolytic activity of S. epidermidis is largely determined by production of PSMδ is in accordance with the observed low production of PSMδ and overall low cytolytic activity of all tested S. epidermidis strains. Thus, although S. epidermidis has the capacity to secrete a potent cytolytic toxin, PSMδ, it limits hemolysis or lysis of neutrophils by keeping production of PSMδ at a low level.

Deformylation of N-formyl methionine in PSMs

The N-formyl methionine group present at the N-terminus of newly synthesized bacterial proteins is recognized by immune cells as a pathogen-associated molecular pattern (PAMP) [37]. Removal of the N-formyl group by bacterial peptide deformylase thus serves to evade recognition by human innate host defense. N-formylated bacterial proteins commonly are not exported with N-formyl-methionine, as their signal peptides are removed during export. In contrast, PSMs are secreted as the unaltered translation product by a yet unidentified mechanism and thus always carry N-formyl methionine, likely representing a very considerable portion of N-formylated peptides released by staphylococci [10]. In S. aureus LAC culture filtrates, about one-half of the total PSM peptide was N-deformylated, which is in good accordance with a previous report on δ-toxin deformylation in another S. aureus strain [38]. In remarkable contrast, no significant deformylation was detected in S. epidermidis PSMs (Fig. 6). Thus, despite the presence of a peptide deformylase in S. epidermidis that is highly homologous to the S. aureus enzyme (80% identity on the amino acid level), proteins are not N-deformylated in S. epidermidis as efficiently as in S. aureus.

Proinflammatory capacity of S. epidermidis culture filtrates and PSMs

In addition to causing cytolysis, PSMs of S. aureus are known to stimulate neutrophil and monocyte chemotaxis, activate neutrophils, and elicit release of the chemokine IL-8 [10]. These proinflammatory capacities of PSMs indicate that the innate immune system recognizes PSMs as PAMPs, which as we recently discovered is achieved by recognition of PSMs by the FPR2/ALX receptor [39]. To determine S. epidermidis proinflammatory capacities, we analyzed stimulation of IL-8 release (Fig. 7A). IL-8 is an important chemokine that causes recruitment of neutrophils to the site of infection [40]. PSMδ had very strong capacity to stimulate release of IL-8; but overall, stimulation of IL-8 release did not correlate with the cytolytic capacities of PSMs. Notably, all S. epidermidis PSMs to some degree stimulated release of IL-8 despite the lack of cytolytic capacity in several of them. Accordingly, capacities of S. epidermidis culture filtrates to stimulate IL-8 release were in the same range as those of S. aureus LAC (Fig. 7B). Finally, stimulation of IL-8 release was significantly lower for the S. epidermidis agr mutant of strain 1457 compared to the corresponding isogenic wild-type strain, and very low for the natural agr mutant strain O47, in keeping with strict regulation of PSMs by agr [30]. Thus, while the different PSM production pattern in S. epidermidis correlates with considerably reduced neutrophil lysis compared to S. aureus, S. epidermidis PSMs still appear to be recognized efficiently as PAMPs. These results suggest that PSM cytolytic and proinflammatory capacities are dependent on distinct interactions with host cells.

Figure 7
IL-8 release by neutrophils stimulated by S. epidermidis PSMs and culture filtrates.

SepA protease and Aps AMP sensor/resistance regulator of S. epidermidis promote resistance to killing by neutrophils

Our results suggest that S. epidermidis does not use PSM cytolytic activity to a significant extent to evade killing by human neutrophils. However, the capacity of S. epidermidis to cause chronic infections indicates that S. epidermidis has means to inhibit elimination by human professional phagocytes. As an alternative strategy to evade killing by human neutrophils, bacteria may secrete enzymes to destroy – or use mechanisms to decrease – the antimicrobial efficiency of neutrophil bactericidal agents [3]. Among those agents, antimicrobial proteins and peptides likely play an important role in the killing of ingested bacteria [41]. We previously showed that the secreted S. epidermidis protease SepA has strong capacity to destroy human AMPs [21]. In addition, we identified a system that we named Aps (for antimicrobial peptide sensor) that senses the presence of human AMPs and coordinates a series of AMP resistance mechanisms in S. epidermidis [22] and S. aureus [24]. While the mechanistic function of these loci is thus well understood, evidence for a significant role of Aps and SepA in immune evasion using human cells is lacking. Therefore, we investigated whether S. epidermidis SepA and S. epidermidis and S. aureus Aps contribute to survival after uptake by human neutrophils. Isogenic sepA and aps mutants of S. epidermidis 1457 had significantly reduced ability to survive after phagocytic interaction with human neutrophils compared to the wild-type strain (Fig. 8), providing evidence for an important function of the aps and sepA loci in S. epidermidis immune evasion. Similarly, the Aps system had a significant impact on the survival of the S. aureus CA-MRSA strain MW2 after phagocytosis. Of note, this effect was comparable to that of the psmα locus, which encodes the most important cytolytic PSM peptides of S. aureus (Fig. 8B,C). These findings indicate that the Aps AMP-sensing system has an important immune evasion task in both species, while only S. aureus makes additional use of cytolytic toxins, such as PSMs, to evade killing by human neutrophils. This discrepancy is reflected by the higher capacity of S. aureus to survive interaction with human neutrophils compared to S. epidermidis (Fig. 8).

Figure 8
Survival of aps and sepA deletion mutants in human neutrophils.


As a commensal organism living on the human skin, S. epidermidis commonly has a benign relationship with its host and may even contribute to reducing inflammatory responses [2], [42]. However, S. epidermidis may cause infection after breach of the epithelial barrier and entry into the bloodstream, such as through contamination of indwelling medical devices during surgery. Although most S. epidermidis infections are only moderately severe and usually chronic, their sheer frequency poses a considerable problem, predominantly in the hospital setting [2], [43]. Despite the immense importance of S. epidermidis infections for public health, the interaction of S. epidermidis with host defenses is poorly understood. In particular, it has not been investigated in detail if and how S. epidermidis resists killing by human neutrophils, which are largely responsible for elimination of invading bacteria. Therefore, we here investigated the interaction of S. epidermidis with neutrophils. As direct lysis of neutrophils by bacterial cytolysins is an efficient means to evade killing, we focused our investigation on PSMs as the only S. epidermidis gene products with potential cytolytic activity [14], [28].

A major finding of our study was the identification of PSMδ as the first S. epidermidis toxin with significant cytolytic capacity. However, despite the cytolytic potential of PSMδ, culture filtrates of S. epidermidis strains had very low capacity to lyse human neutrophils. Importantly, according to our findings this phenotypic difference between virulent S. aureus and S. epidermidis is caused at least in part by a pattern of PSM production in S. epidermidis that is shifted, compared to S. aureus, to PSMs with lower cytolytic potential. Thus, PSMs in S. epidermidis do not contribute significantly to neutrophil lysis, in contrast to many virulent strains of S. aureus. Likely, PSMs fulfill other roles in S. epidermidis that are yet poorly understood, such as in biofilm development [44] or bacterial interference [33]. The production of PSMs that are not potent cytotoxins would thus ascertain that S. epidermidis may cause chronic, biofilm-associated infection without promoting acute, purulent inflammation. This is in keeping with a general strategy of S. epidermidis to reside inside the human host in a state of “hiding” from the immune system. Potentially, a similar strategy is pursued by strains of S. aureus, such as functionally Agr-negative strains, which are less virulent, cause chronic rather than acute infection, and produce less cytolytic toxins, such as PSMs.

In addition, our study revealed significant contributions of the SepA protease and the Aps AMP sensor/regulator to promoting S. epidermidis survival in human neutrophils. Thus, S. epidermidis is able to combat important mechanisms that neutrophils use to kill bacteria after phagocytosis. However, together with previous findings on S. aureus survival in human neutrophils [27], our data indicate that these mechanisms are not as efficient as leukocyte toxins, underlining the notion that S. epidermidis is in general less virulent than S. aureus as a result of lower capacity to survive after neutrophil phagocytosis. This is in accordance with a very early study that showed increased survival of “pathogenic” (i.e. coagulase-positive) versus “non-pathogenic” (i.e. coagulase-negative) staphylococci in human leukocytes [45]. Nevertheless, our study shows that - combined with mechanisms preventing neutrophil phagocytosis, such as surface exopolymers and biofilm formation - S. epidermidis has a multi-faceted program providing resistance to neutrophil killing, explaining at least in part the capacity of S. epidermidis to cause long-lasting infection in the susceptible host. Moreover, as we have shown previously that SepA production is under control of Agr and SarA [21], our findings confirm the notion that global regulatory systems play key roles in S. epidermidis immune evasion [46], and are reminiscent of similar functions of Agr and SarA in S. aureus [47], [48]. Finally, the observed significant effects of AMP resistance mechanisms on survival in neutrophils underline the importance of non-oxygen-dependent antimicrobial processes of the host.

Collectively, our findings indicate that the molecular mechanisms that S. epidermidis uses to evade elimination by innate host defense reflect a passive defense strategy rather than use of aggressive toxins and point to a different major role of PSM production in S. epidermidis compared to S. aureus.

Materials and Methods

Ethics statement

Human neutrophils were obtained from healthy volunteers in accordance with a protocol approved by the Institutional Review Board for Human Subjects, NIAID. Informed written consent was received from human volunteers.

Bacterial strains and growth conditions

Bacterial strains used in this study were S. epidermidis strains 1457 [49], RP62A [14], [50], ATCC12228 [28], O47 [51], isogenic agr, sepA, and apsS deletion mutants of strain 1457 [21], [22], [52], S. aureus strains LAC (pulsed-field type USA300) [53] and MW2 (pulsed-field type USA400) [54] and the isogenic aps and psmα mutants of strain MW2 [24]. LAC and MW2 are virulent community-associated MRSA strains. Strains were grown in tryptic soy broth (TSB). The psmδ over-expression plasmid pTXpsmδ [34] was transformed in S. epidermidis agr. Expression of PSMδ by this construct is achieved by adding xylose, which acts on a xylose-inducible promoter in front of the cloned psmδ gene [55].

Peptide synthesis

PSM peptides were synthesized by commercial vendors with an N-terminal formyl methionine residue in each peptide. Peptide sequence fidelity was determined by the Peptide Synthesis Unit of the NIAID. Peptide stock solutions were prepared at 10 mg/ml in DMSO (dimethylsulfoxide); further dilutions were made in water.

Neutrophil preparation and lysis assays

PMNs were isolated from venous blood of healthy volunteers as described [56]. Lysis of PMNs by synthetic PSMs or clarified S. aureus or S. epidermidis culture media was determined essentially as described [27], [56]. Synthetic PSMs were added to wells of a 96-well tissue culture plate containing 106 PMNs and plates were incubated at 37°C. After 1 h, PMN lysis was determined by release of lactate dehydrogenase (LDH) (Cytotoxicity Detection Kit, Roche Applied Sciences). Alternatively, S. aureus and S. epidermidis strains were cultured for 18 h at 37°C in 50 ml TSB (+/− 0.5% xylose) with shaking using a 100 ml flask. Bacteria were removed by centrifugation and culture media were sterilized by filtration and stored at −80°C in aliquots until used. Culture medium was mixed with human PMNs (106) and tested for its ability to cause PMN lysis using incubation times of up to 6 h, as indicated.

Resistance of S. epidermidis and S. aureus to killing by human neutrophils

For measurement of S. epidermidis/S. aureus survival after phagocytic interaction with neutrophils, PMNs (106) in RPMI were combined with ~107 RPMI-washed bacteria from mid-logarithmic growth phase in 96-well flat-bottom microtiter plates. Plates were centrifuged at 380×g for 8 min to synchronize phagocytosis and incubated at 37°C for up to 1 h. At the desired time points, 22 µl of 1% saponin was added, well contents were mixed, and the plates were incubated on ice for 15 min. Surviving bacteria were enumerated. % survival was calculated by comparing the numbers of surviving bacteria to those at t = 0.

Cytokine production assay

After isolation and washing, neutrophils were resuspended in RPMI 1640 medium (Sigma) supplemented with 10% human serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 2 mM sodium pyruvate, and 10 mM HEPES. Cells were distributed to a 96-well culture plate at 200 µl and 5×105 cells per well. Synthetic PSMs or filtered bacterial culture supernatants were diluted in fresh culture medium (1[ratio]100) and added to the plate at 100 µl/well. Plates were incubated at 37°C in a 5.5% CO2 incubator for 5 h. Then, the plate was centrifuged at 1500 rpm for 10 min, and supernatant was harvested from each well. IL-8 was measured in the culture supernatants with commercial ELISA assay kits (R&D systems) according to the manufacturer's instructions. Diluted culture filtrates were further diluted 1[ratio]2 for the ELISA.

Hemolysis assay

Hemolytic activities of culture filtrates from 18-h cultures of S. epidermidis strains or synthetic PSM peptides at different concentrations were determined by incubating samples with sheep red blood cells (2% v/v in Dulbecco's phosphate-buffered saline, DPBS) for 1 h at 37°C as previously described [10]. Assays were performed in triplicate.

Analysis of PSM production

RP-HPLC/ESI-MS was performed on an Agilent 1100 chromatography system coupled to a Trap SL mass spectrometer using a Zorbax SB-C8 2.3×30 mm column as described [30]. Quantification was based on extracted ion chromatograms using the most abundant peaks of the electrospray ion mass spectra of the respective PSM peptides, with calibration using synthetic peptides, as described [30].

Circular dichroism spectroscopy

The structures of synthetic PSM peptides were analyzed by CD spectroscopy on a Jasco spectropolarimeter model J-720 instrument. Solutions of PSM peptides, each at 1.0 mg/ml, were prepared in 50% trifluoroethanol. Measurements were performed in triplicate and the resulting scans were averaged, smoothed, and the buffer signal was subtracted. Computation of relative fraction of helix, sheet, turn, and unordered structure, using 3 different algorithms, was performed according to Sreerama and Woody [57].

Statistical analyses

Statistical analyses were performed with Graph Pad Prism 5 software using t-tests or 1-way ANOVA with Bonferroni or Dunnett post tests, as appropriate.


The authors have declared that no competing interests exist.

This study was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol. 2008;322:207–228. [PMC free article] [PubMed]
2. Otto M. Staphylococcus epidermidis - the ‘accidental’ pathogen. Nat Rev Microbiol. 2009;7:555–567. [PMC free article] [PubMed]
3. Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev. 2007;219:88–102. [PubMed]
4. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–1322. [PubMed]
5. Kocianova S, Vuong C, Yao Y, Voyich JM, Fischer ER, et al. Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest. 2005;115:688–694. [PMC free article] [PubMed]
6. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 2004;6:269–275. [PubMed]
7. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3:948–958. [PubMed]
8. Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol. 2005;13:596–601. [PubMed]
9. Woodin A. Staphylococcal leukocidin. In: Montje T, Kadis S, Ajl S, editors. Microbial toxins. New York: Academic Press, Inc; 1970. pp. 327–355.
10. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med. 2007;13:1510–1514. [PubMed]
11. McKevitt AI, Bjornson GL, Mauracher CA, Scheifele DW. Amino acid sequence of a deltalike toxin from Staphylococcus epidermidis. Infect Immun. 1990;58:1473–1475. [PMC free article] [PubMed]
12. Mehlin C, Headley CM, Klebanoff SJ. An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med. 1999;189:907–918. [PMC free article] [PubMed]
13. Yao Y, Sturdevant DE, Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis. 2005;191:289–298. [PubMed]
14. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005;187:2426–2438. [PMC free article] [PubMed]
15. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol. 2001;166:15–19. [PubMed]
16. Klebanoff SJ, Kazazi F, Van Voorhis WC, Schlechte KG. Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product. Proc Natl Acad Sci U S A. 1994;91:10615–10619. [PubMed]
17. Liles WC, Thomsen AR, O'Mahony DS, Klebanoff SJ. Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin. J Leukoc Biol. 2001;70:96–102. [PubMed]
18. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol. 2006;177:3162–3169. [PubMed]
19. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5:1317–1327. [PubMed]
20. Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 2000;8:402–410. [PubMed]
21. Lai Y, Villaruz AE, Li M, Cha DJ, Sturdevant DE, et al. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol. 2007;63:497–506. [PubMed]
22. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, et al. Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A. 2007;104:9469–9474. [PubMed]
23. Herbert S, Bera A, Nerz C, Kraus D, Peschel A, et al. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 2007;3:e102. [PMC free article] [PubMed]
24. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, et al. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol. 2007;66:1136–1147. [PubMed]
25. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem. 1999;274:8405–8410. [PubMed]
26. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 2001;193:1067–1076. [PMC free article] [PubMed]
27. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol. 2005;175:3907–3919. [PubMed]
28. Zhang YQ, Ren SX, Li HL, Wang YX, Fu G, et al. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol. 2003;49:1577–1593. [PubMed]
29. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, et al. RNAIII-Independent Target Gene Control by the agr Quorum-Sensing System: Insight into the Evolution of Virulence Regulation in Staphylococcus aureus. Mol Cell. 2008;32:150–158. [PMC free article] [PubMed]
30. Vuong C, Durr M, Carmody AB, Peschel A, Klebanoff SJ, et al. Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell Microbiol. 2004;6:753–759. [PubMed]
31. Mellor IR, Thomas DH, Sansom MS. Properties of ion channels formed by Staphylococcus aureus delta-toxin. Biochim Biophys Acta. 1988;942:280–294. [PubMed]
32. Talbot JC, Thiaudiere E, Vincent M, Gallay J, Siffert O, et al. Dynamics and orientation of amphipathic peptides in solution and bound to membranes: a steady-state and time-resolved fluorescence study of staphylococcal delta-toxin and its synthetic analogues. Eur Biophys J. 2001;30:147–161. [PubMed]
33. Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol. 2010;130:192–200. [PMC free article] [PubMed]
34. Otto M, O'Mahoney DS, Guina T, Klebanoff SJ. Activity of Staphylococcus epidermidis phenol-soluble modulin peptides expressed in Staphylococcus carnosus. J Infect Dis. 2004;190:748–755. [PubMed]
35. Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis. 2004;190:1498–1505. [PubMed]
36. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis. 2003;188:706–718. [PubMed]
37. Le Y, Murphy PM, Wang JM. Formyl-peptide receptors revisited. Trends Immunol. 2002;23:541–548. [PubMed]
38. Somerville GA, Cockayne A, Durr M, Peschel A, Otto M, et al. Synthesis and deformylation of Staphylococcus aureus delta-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol. 2003;185:6686–6694. [PMC free article] [PubMed]
39. Kretschmer D, Gleske A, Rautenberg M, Wang R, Koberle M, et al. Cell Host Microbe. In press; 2010. Human formyl peptide receptor 2 (FPR2/ALX) senses highly pathogenic Staphylococcus aureus. [PMC free article] [PubMed]
40. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci. 2008;13:2400–2407. [PubMed]
41. Nizet V. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol. 2007;120:13–22. [PubMed]
42. Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009;15:1377–1382. [PMC free article] [PubMed]
43. Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002;4:481–489. [PubMed]
44. Kong KF, Vuong C, Otto M. Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol. 2006;296:133–139. [PubMed]
45. Rogers DE, Tompsett R. The survival of staphylococci within human leukocytes. J Exp Med. 1952;95:209–230. [PMC free article] [PubMed]
46. Yao Y, Vuong C, Kocianova S, Villaruz AE, Lai Y, et al. Characterization of the Staphylococcus epidermidis Accessory-Gene Regulator Response: Quorum-Sensing Regulation of Resistance to Human Innate Host Defense. J Infect Dis. 2006;193:841–848. [PubMed]
47. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol. 2000;164:3713–3722. [PubMed]
48. Shompole S, Henon KT, Liou LE, Dziewanowska K, Bohach GA, et al. Biphasic intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated diffusion sensing. Mol Microbiol. 2003;49:919–927. [PubMed]
49. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, et al. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun. 1994;62:3244–3253. [PMC free article] [PubMed]
50. Christensen GD, Bisno AL, Parisi JT, McLaughlin B, Hester MG, et al. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med. 1982;96:1–10. [PubMed]
51. Heilmann C, Gerke C, Perdreau-Remington F, Gotz F. Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun. 1996;64:277–282. [PMC free article] [PubMed]
52. Vuong C, Gotz F, Otto M. Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun. 2000;68:1048–1053. [PMC free article] [PubMed]
53. CDC Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002–2003. MMWR Morb Mortal Wkly Rep. 2003;52:88. [PubMed]
54. CDC From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997-1999. Jama. 1999;282:1123–1125. [PubMed]
55. Peschel A, Ottenwalder B, Gotz F. Inducible production and cellular location of the epidermin biosynthetic enzyme EpiB using an improved staphylococcal expression system. FEMS Microbiol Lett. 1996;137:279–284. [PubMed]
56. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, et al. Is Panton-Valentine Leukocidin the Major Virulence Determinant in Community-Associated Methicillin-Resistant Staphylococcus aureus Disease? J Infect Dis. 2006;194:1761–1770. [PubMed]
57. Sreerama N, Woody RW. Computation and analysis of protein circular dichroism spectra. Methods Enzymol. 2004;383:318–351. [PubMed]

Articles from PLoS Pathogens are provided here courtesy of Public Library of Science